Socratis Avgeris

Mr. Socratis Avgeris


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2022 in Cells
Verified
Journal Article
Open access
PDF file
ETEirini Taouktsi
Eirini Taouktsi
EKEleni Kyriakou
Eleni Kyriakou
SSStefanos Smyrniotis
Stefanos Smyrniotis
FBFivos Borbolis
Fivos Borbolis
LBLabrina Bondi
Labrina Bondi
PSPopi Syntichaki
Popi Syntichaki
Cells engage complex surveillance mechanisms to maintain mitochondrial function and protein homeostasis. LonP1 protease is a key component of mitochondrial quality control and has been implicated in human malignancies and other pathological disorders. Here, we employed two experimental systems, the worm Caenorhabditis elegans and human cancer cells, to investigate and compare the effects of LONP-1/LonP1 deficiency at the molecular, cellular, and organismal levels. Deletion of the lonp-1 gene in worms disturbed mitochondrial function, provoked reactive oxygen species accumulation, and impaired normal processes, such as growth, behavior, and lifespan. The viability of lonp-1 mutants was dependent on the activity of the ATFS-1 transcription factor, and loss of LONP-1 evoked retrograde signaling that involved both the mitochondrial and cytoplasmic unfolded protein response (UPRmt and UPRcyt) pathways and ensuing diverse organismal stress responses. Exposure of worms to triterpenoid CDDO-Me, an inhibitor of human LonP1, stimulated only UPRcyt responses. In cancer cells, CDDO-Me induced key components of the integrated stress response (ISR), the UPRmt and UPRcyt pathways, and the redox machinery. However, genetic knockdown of LonP1 revealed a genotype-specific cellular response and induced apoptosis similar to CDDO-Me treatment. Overall, the mitochondrial dysfunction ensued by disruption of LonP1 elicits adaptive cytoprotective mechanisms that can inhibit cancer cell survival but diversely modulate organismal stress response and aging.

Verified
Journal Article
Open access
PDF file
AGAikaterini F. Giannopoulou
Aikaterini F. Giannopoulou
EKEvmorfia (Eumorphia) Konstantakou
Evmorfia (Eumorphia) Konstantakou
Athanassios VelentzasAthanassios Velentzas
Athanassios Velentzas
SASocratis Avgeris
Socratis Avgeris
Margaritis AvgerisMargaritis Avgeris
Margaritis Avgeris
Dimitrios StravopodisDimitrios Stravopodis
Dimitrios Stravopodis
Background: Skin cancer represents the most common human malignancy, and it includes BCC, SCC, and melanoma. Since melanoma is one of the most aggressive types of cancer, we have herein attempted to develop a gene-specific intron retention signature that can distinguish BCC and SCC from melanoma biopsy tumors. Methods: Intron retention events were examined through RT-sqPCR protocols, using total RNA preparations derived from BCC, SCC, and melanoma Greek biopsy specimens. Intron-hosted miRNA species and their target transcripts were predicted via the miRbase and miRDB bioinformatics platforms, respectively. Ιntronic ORFs were recognized through the ORF Finder application. Generation and visualization of protein interactomes were achieved by the IntAct and Cytoscape softwares, while tertiary protein structures were produced by using the I-TASSER online server. Results: c-MYC and Sestrin-1 genes proved to undergo intron retention specifically in melanoma. Interaction maps of proteins encoded by genes being potentially targeted by retained intron-accommodated miRNAs were generated and SRPX2 was additionally delivered to our melanoma-specific signature. Novel ORFs were identified in MCT4 and Sestrin-1 introns, with potentially critical roles in melanoma development. Conclusions: The property of c-MYC, Sestrin-1, and SRPX2 genes to retain specific introns could be clinically used to molecularly differentiate non-melanoma from melanoma tumors.

6 May 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
APAdamantia Papadopoulou
Adamantia Papadopoulou
SASocratis Avgeris
Socratis Avgeris
STSavvas Thysiadis
Savvas Thysiadis
CSChristos Siokatas
Christos Siokatas
SAStelios Astaras
Stelios Astaras
Dimitris KletsasDimitris Kletsas
Dimitris Kletsas
Ninety-five structurally diverse chemically synthesized compounds, retrieved from the chemical library of the national research infrastructure OPENSCREEN-GR, were subjected here to a structure-agnostic bioactivity-driven screen focused on putative anti-cancer activities using a number of human cell lines derived from diverse types of cancer. Interestingly, the top four compounds that displayed a broad anti-cancer activity (with no apparent photosensitizing activity) during unbiased biological evaluation were then identified as phenoxazine derivatives. In addition to their cytotoxic activity, phenoxazine derivatives BS115 and ST61 were also found to be cytostatic by inducing a p53-independent G2/M cell cycle arrest as well as a G0/G1 arrest only in cells harboring a functional p53. A kinetics analysis using two multiplex immunoassays and siRNA-mediated knockdown of HSP27 revealed that the latter protein is a key molecule in the response of cancer cells to ST61 via its phosphorylation by p38 MAPK. The main mechanism underlying ST61’s anti-cancer activity was found to involve oxidative stress, as scavenging of ST61-induced reactive oxygen species by N-acetyl-cysteine led to the abrogation of the compound’s cytotoxic effect.